BlackRock’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Hold
139,533
﹤0.01% 4640
2025
Q4
$483K Buy
139,533
+58,858
+73% +$177K ﹤0.01% 4494
2025
Q3
$167K Hold
80,675
﹤0.01% 4717
2025
Q2
$175K Sell
80,675
-19,954
-20% -$39.4K ﹤0.01% 4701
2025
Q1
$151K Sell
100,629
-11,350
-10% -$34.7K ﹤0.01% 4660
2024
Q4
$563K Buy
111,979
+10,484
+10% +$75.9K ﹤0.01% 4378
2024
Q3
$818K Buy
101,495
+786
+0.8% +$7.37K ﹤0.01% 4221
2024
Q2
$580K Buy
100,709
+3,080
+3% +$25K ﹤0.01% 4307
2024
Q1
$1.16M Buy
97,629
+1,645
+2% +$17.9K ﹤0.01% 4161
2023
Q4
$1.79M Sell
95,984
-297
-0.3% -$2.63K ﹤0.01% 4078
2023
Q3
$914K Sell
96,281
-1,012
-1% -$12.5K ﹤0.01% 4276
2023
Q2
$1.39M Buy
97,293
+3,047
+3% +$43.1K ﹤0.01% 4192
2023
Q1
$1.45M Sell
94,246
-8,950
-9% -$145K ﹤0.01% 4197
2022
Q4
$1.39M Sell
103,196
-41,253
-29% -$516K ﹤0.01% 4291
2022
Q3
$1.98M Sell
144,449
-2,363
-2% -$31.1K ﹤0.01% 4202
2022
Q2
$1.66M Sell
146,812
-881
-0.6% -$9.63K ﹤0.01% 4324
2022
Q1
$1.97M Buy
147,693
+94
+0.1% +$1.36K ﹤0.01% 4404
2021
Q4
$2.6M Buy
147,599
+44,269
+43% +$1.14M ﹤0.01% 4300
2021
Q3
$3.28M Buy
103,330
+2,333
+2% +$134K ﹤0.01% 4116
2021
Q2
$8.64M Buy
+100,997
New +$4.67M ﹤0.01% 3694

Other funds holding ANVS

BlackRock's ANVS Position: Q1 2026 in Review

BlackRock held its Annovis Bio (ANVS) position steady in Q1 2026 at 139,533 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #4640.

BlackRock first reported a position in ANVS in Q2 2021 and has held it in 20 quarters since. The position peaked at $8.64M in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • BlackRock held 139,533 shares of Annovis Bio worth $311K as of Q1 2026.
  • BlackRock left its Annovis Bio share count unchanged in Q1 2026.
  • Annovis Bio made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4640 holding.
  • BlackRock first reported a position in Annovis Bio in Q2 2021 and has held it in 20 quarters since.
  • BlackRock's Annovis Bio position peaked at $8.64M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.